Clinical Oncology Next-generation Sequencing MarketThe clinical oncology next-generation sequencing market share is expected to reach a value of US$ 449.4 million by 2022. Owing to the increasing application of next-generation sequencing (NGS) in clinical oncology for more effective, individualised cancer treatment,.
MGI Tech, a company committed to building core tools and technology to lead life science, today announced the signing of a sales agreement with ADK Trading and Shipping at Medlab Middle East 2024. The agreement includes the installation of mid-low throughput gene sequencer DNBSEQ-G99 , automated sample preparation system MGISP-100, and bioinformatics analysis accelerator Megabolt.
Until now, scientists didn't know what exactly made pee yellow — and the answer may be situated a bit north of the bladder. In a new study published in the journal Nature Microbiology, a multidisciplinary group of scientists out of the University of Maryland reported on their findings about a middleman enzyme called bilirubin reductase, which […]
BGI boosts global crop yields and cost reductions for farmers shanghaiist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shanghaiist.com Daily Mail and Mail on Sunday newspapers.
Global Next-Generation Sequencing Technology Market Set to Reach USD 43 41 Billion by 2030, According to Infinium Global Research finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.